September 2, 2026 | Aspen Pharmacare

Share Price:

APNASPENAspen Pharmacare Hldgs15444944 (6.51%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

FY2026 Annual Results Short Form Announcement

View or Download

FY2026 Annual Results Booklet

View or Download

FY2026 Annual Results Presentation

View or Download

FY 2026 Annual Results Presentation webcast

Watch the webcast

Strong execution positions Aspen for sustainable growth

FY 2026 marked a significant inflection point for Aspen as the Group delivered strong normalised earnings growth, improved profitability across both Commercial Pharmaceuticals and Manufacturing, and successfully completed the APAC divestment.

We Care

Ethics & Compliance Management

SED Initiatives

Mandela Day

Our Sustainability Commitments

Working At Aspen

Bursary Applications

We Care

Ethics & Compliance Management

SED Initiatives

Mandela Day

Our Sustainability Commitments

Working At Aspen

Bursary Applications

Our Purpose

Find out more

To improve the health and quality of life of patients.

Our Vision

Find out more

To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.

Our Values

Find out more

Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026. The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

View our teams below:

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.